The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.
March 28th 2024
The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Dr Robert Gabbay Explains the Development of the ADA's New CKD Guidelines
February 4th 2022Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), discusses the development process for the section of ADA guidelines that touches on chronic kidney disease (CKD) management in patients with diabetes.
Watch
New Section on Chronic Kidney Disease Risk Management Added to ADA Standard of Care Guidelines
January 27th 2022The American Diabetes Association (ADA) has added a new section to their 2022 Standard of Care guidelines to assist clinicians in managing and preventing the presence of chronic kidney disease and related complications in patients with diabetes.
Read More
Gender Differences for Health-Related QOL Detected Among Patients With Advanced Kidney Disease
January 24th 2022Although men and women with advanced kidney disease experienced physical and mental declines in health-related quality of life (QOL), men’s declines occurred at a significantly faster rate, researchers concluded.
Read More
Study: Which AI Model Is the Best at Detecting Early-Stage CKD?
January 19th 2022A study comparing 4 different artificial intelligence (AI) models found that some models were better than others at detecting early-stage chronic kidney disease (CKD), when patients do not experience visible symptoms.
Read More
Apixaban Cuts Recurrent Venous Thromboembolism Risk in CKD Better Than Warfarin
January 9th 2022Risk of recurrent venous thromboembolism (VTE) in patients with chronic kidney disease (CKD) and VTE was significantly reduced in those who were treated with apixaban vs warfarin, investigators concluded.
Read More
Review: Greater Focus on Targeting Insulin Resistance in Patients With CKD May Be Needed
January 7th 2022Insulin resistance may become a future target of treatment in the chronic kidney disease (CKD) population because of the several mechanisms in patients that contribute to increasing resistance, authors of a review concluded.
Read More
Focus Group Expresses Needs, Wants for a Mobile CKD Management App
December 30th 2021A focus group consisting of patients with chronic kidney disease (CKD) as well as CKD providers and researchers shared what they deem necessary and helpful to include in future mobile CKD management applications.
Read More
Dialysis Modality Influenced Degree of Pandemic-Related Psychological Distress in Patients With CKD
December 17th 2021Patients with chronic kidney disease (CKD) undergoing hemodialysis experienced a greater degree of psychological distress during the COVID-19 pandemic compared with patients treated with peritoneal dialysis, investigators found.
Read More
Acute Kidney Injury Episodes Led to Significant Impacts on Physical, Emotional Health
December 13th 2021Patients who have experienced acute kidney injury (AKI) reported experiencing significant impacts on aspects of their physical and emotional health, demonstrating the different ways that AKI episodes influence patients’ health-related quality of life.
Read More
Study: Heating Climate Can Lead to Higher Risks of Mortality, Hospitalization in Patients With ESRD
December 9th 2021Rising ambient temperatures were found to be associated with higher risks of all-cause mortality and all-cause hospitalization in patients with end-stage renal disease (ESRD), highlighting the some of the health-related consequences of climate change.
Read More
Views on Telehealth vs In-Person Care Diverge Among Patients With CKD, Clinicians
December 6th 2021Opinions on the effectiveness and usefulness of telehealth services varied among clinicians and older patients with chronic kidney disease (CKD), suggesting that new measures and training programs should be put in place to mitigate disparities and accessibility issues.
Read More
Potential Link Found Between Vitamin D Therapy, Higher Hypercalcemia Risk in CKD
December 4th 2021Patients with chronic kidney disease (CKD) and elevated levels of parathyroid hormone who are treated with active vitamin D therapy experienced significantly higher risks of hypercalcemia, investigators concluded in a meta-analysis.
Read More
Nomogram Tool Can Predict Risk of CKD in Patients at High Risk of Developing Cardiovascular Disease
December 1st 2021A tool utilizing 5 predictors was found to be reliable at identifying patients at a high risk of cardiovascular disease who were also at risk of developing chronic kidney disease (CKD), potentially allowing providers to implement prevention strategies sooner than ever before.
Read More
Contributor: Equity, Not Equality, Is Needed to Close Racial Gap in Chronic Kidney Disease Outcomes
November 24th 2021Improving clinical care is only one element of the 360-degree, holistic treatment that is necessary to achieve patient equity, not equality, in patients with chronic kidney disease. Biology, lifestyle, and socioeconomic status are 3 areas in which inequities often have a particularly negative impact on a carefully constructed care plan.
Read More
Dr Robert Gabbay Discusses ADA's Efforts to Address Effect of Diabetes on Kidney Disease
November 21st 2021Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association (ADA), describes the ADA's efforts to elevate the conversation about the impact of diabetes on kidney disease.
Watch
Increased Heart Rate Found to Be Associated With Kidney Function Declines in Transplant Recipients
November 16th 2021Investigators found that increased heart rate correlated with a decline in the ability for the kidneys to function at 48 weeks after a patient receives a kidney transplant, according to results presented at the 2021 American Heart Association Scientific Sessions.
Read More
AKI Hospitalizations Found to Be Risk Factor for Postdischarge Adverse Events
November 8th 2021Hospitalization for an acute kidney injury (AKI) event was identified as a risk factor for several adverse events after hospital discharge, including hospital readmission and mortality, according to findings presented at Kidney Week 2021.
Read More
AMCP Nexus Abstracts Present Findings on Clinical, Financial Burdens Associated With CKD
November 8th 2021Conference abstracts explored the relationship between serum phosphate levels on mortality in patients with chronic kidney disease (CKD) and cost burdens for employers as patients transition to end-stage renal disease.
Read More
Daprodustat Shows Favorable Safety in Treating Anemia in CKD With, Without Dialysis
November 6th 2021Daprodustat had no increased cardiovascular risk, compared with erythropoiesis stimulating agents (ESAs), in treating anemia in patients with chronic kidney disease (CKD) who were on dialysis and not on dialysis.
Read More